Industries / Health / Healthcare / Medical spas
Lasers and light
This work aims a laser beam, or a flash of bright ordinary light, at one target in the skin, such as the dark pigment in a hair root, the blood in a small vein, the ink in a tattoo or a column of aged skin, and heats that target while sparing the skin around it.
7
Milestones achieved, from 1963 to 2012.
1
To watch for: announced, not yet confirmed outside.
2
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
1963
A laser aimed at skin
In March 1963 Leon Goldman's laboratory at the University of Cincinnati published a preliminary report on the effect of a laser beam on skin in the Journal of Investigative Dermatology, three years after the laser was invented. By January 1965 the group had fired a Q-switched ruby laser, which gives very short and very powerful pulses, again and again at a man's tattoo. Goldman became the founding president of the American Society for Laser Medicine and Surgery.
LessonGoldman kept a rule on his laboratory wall, "If you don't need the laser, don't use it.".
Credit
Leon Goldman, University of Cincinnati
1983
Aim by color and timing
R. Rox Anderson and J. A. Parrish showed in Science that a pulse of light in a color the target absorbs, kept short enough, damages that target and little else, so precise aiming is unnecessary. A 577-nanometer pulse of 0.3 microseconds damaged the small blood vessels in skin, and a 351-nanometer pulse damaged the pigment granules in skin cells. They called the method selective photothermolysis. Laser treatment of hair, veins, brown spots and tattoos rests on it.
Credit
R. Rox Anderson and J. A. Parrish
1995
Hair removal sold, then regrown
On 3 April 1995 the FDA cleared a Q-switched Nd:YAG laser from ThermoLase for hair removal. In ThermoLase's SoftLight method a lotion of carbon powder in mineral oil was first massaged into the skin to soak up the laser light, and the company sold the treatment in its own day spas. In 1997 C. A. Nanni and Tina Alster reported that hair delayed by this method had fully regrown at every treated site by six months. In June 1999 ThermoLase sold its remaining day spas, five others already closed, and booked a loss of about $31 million on the spa business, while it faced lawsuits claiming its hair-removal marketing was misleading.
LessonA clearance lets a device be sold; it does not show how long the result lasts.
Credit
ThermoLase Corporation; C. A. Nanni and Tina Alster for the outside test
1995
Flashlamps join lasers
On 7 August 1995 the FDA cleared the PhotoDerm VL from ESC Energy Systems, a flashlamp that fires intense pulses of ordinary light filtered to a band of colors, for leg veins. In a 1996 multicenter study of 159 patients run with the company, 79% of treated veins cleared by 75% to 100%. Intense pulsed light (IPL), as such lamps are called, spread to redness, brown spots and hair removal. A 2003 review by Christian Raulin and colleagues gives its spectrum as 515 to 1,200 nanometers and warns that its many settings demand experience.
Credit
ESC Medical Systems; M. P. Goldman and S. Eckhouse for the first study
2001
Longer waves for darker skin
Lasers that aim at the dark pigment in hair also heat the same pigment in the skin around it, which puts darker skin at risk. Tina Alster, H. Bryan and C. M. Williams in Washington, DC treated 20 women with skin types IV to VI on the Fitzpatrick scale, the darker end, with a long-pulsed Nd:YAG laser at 1,064 nanometers. Two independent assessors graded photographs: hair was reduced by 70% to 90% twelve months after three monthly sessions, with rare blistering, passing color change and no scarring.
Credit
Tina Alster and colleagues
2004
Heat in tiny columns
Dieter Manstein, R. Rox Anderson and colleagues introduced fractional photothermolysis: a laser at 1.5 micrometers burns a grid of columns about 0.1 millimeter wide and 0.3 millimeter deep and leaves the skin between them untouched, so the surface heals within a day. In 30 people treated four times around the eyes, wrinkle scores improved 18% three months later. A 2025 study of a newer device describes fractional 1,550-nanometer lasers as the usual treatment for acne scars.
Credit
Dieter Manstein, R. Rox Anderson and colleagues
2012
Picosecond pulses for tattoos
On 27 November 2012 the FDA cleared Cynosure's PicoSure for tattoos and harmless pigmented spots. It is a 755-nanometer alexandrite laser whose pulses last trillionths of a second, about a thousand times shorter than the nanosecond pulses used on tattoos for decades. Roy Geronemus's group in New York reported at least 75% clearance of blue and green ink in 12 tattoos after one or two sessions. Outside trials disagree on how much better it is. A 2017 randomized trial in Italy and Germany of 30 black tattoos by F. Pinto, Christian Raulin and colleagues found no difference in clearance between picosecond and nanosecond Nd:YAG lasers after two sessions, only less pain. A 2026 Chinese split-tattoo trial of 30 people found picosecond alexandrite clearer after five sessions, 73.3% of halves rated satisfactory against 23.3%, but with more darkened skin.
LessonA shorter pulse needs a side-by-side trial at the same wavelength before it can be called better.
Credit
Cynosure; Roy Geronemus and colleagues
Watch for
Resurfacing safe on dark skin
AVAVA, a Massachusetts laser maker, says its 1,550-nanometer laser focuses its beam below the surface ("Focal Point Technology") and so cuts the risk of dark patches in darker skin. In a study it funded, 47 people with acne scars across skin types I to VI were treated; 78.0% were rated improved, and one person (2.1%) had lasting darkening, against 57.1% and 40.0% reported for older 1,550-nanometer lasers. Only 6 of the 47 had skin types V or VI, and the authors are AVAVA's advisers, consultants and medical director. The FDA cleared the device for wrinkles, acne scars and resurfacing on 20 October 2025.
Achieved whena trial not funded by AVAVA, with at least 30 people of skin types V and VI, reports its rate of lasting darkening.
Claimed by
AVAVA, Inc. and its clinical advisers, December 2025
Open
01
Eyewear tested past 920 nm
A public table of how much light the goggles and patient eye shields sold for aesthetic lasers and IPL really block, from visible light out to 1,600 nanometers, next to what their labels claim. Blocking is given as optical density, a scale on which each step stops ten times more light. The measurements use a laboratory spectrophotometer and its lamp; no laser or IPL is fired and nobody wears the eyewear.
The briefCredit · unclaimed02
"All skin types", traced
A public table of every FDA clearance of a laser or light device for hair removal or resurfacing whose indication covers all skin types (Fitzpatrick I to VI), showing what evidence each rests on: the clinical study in its submission, if any, and the number of people of skin types V and VI in it; and if there is none, the chain of earlier devices it was compared with, back to the first one that had such data.
The briefCredit · unclaimed
Open 01 · the brief
Eyewear tested past 920 nm
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public table of how much light the goggles and patient eye shields sold for aesthetic lasers and IPL really block, from visible light out to 1,600 nanometers, next to what their labels claim. Blocking is given as optical density, a scale on which each step stops ten times more light. The measurements use a laboratory spectrophotometer and its lamp; no laser or IPL is fired and nobody wears the eyewear.
Why it is still open
Hyun Jeong Ju and colleagues at St. Vincent's Hospital in Suwon, Korea, published an audit of clinic goggles in February 2026. Most laser goggles met their labels, but several IPL goggles, including branded models, fell short of US safety limits in parts of the 400 to 750 nanometer range. Their instrument stopped at 920 nanometers, so goggles for 1,064-nanometer and 1,550-nanometer lasers were not checked, and they tested a modest number of models. NIST reported in 2017 that some eyewear makers set their ratings with ordinary spectrometers rather than lasers, and that one filter blocked 10,000 times less light than its rating under very short pulses.
Built with what exists
A UV-visible-near-infrared spectrophotometer with a near-infrared detector that reads past 1,100 nanometers, of the kind university chemistry and physics departments keep; calibrated neutral-density filters to show how dark a sample the instrument can still read; goggles and eye shields bought from clinic suppliers and online marketplaces; Python for the table.
First step
Measure three goggles labelled for 1,064 nanometers on a borrowed spectrophotometer, with one neutral-density filter of known value as a check.
Done looks like
At least 40 goggle models and 15 patient eye shields, each with its measured optical density at 532, 755, 810, 1,064 and 1,550 nanometers beside its label, marked "at least" where the label is beyond the instrument's limit, and a second laboratory repeating 5 models to within 0.3 units.
Open 02 · the brief
"All skin types", traced
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
A public table of every FDA clearance of a laser or light device for hair removal or resurfacing whose indication covers all skin types (Fitzpatrick I to VI), showing what evidence each rests on: the clinical study in its submission, if any, and the number of people of skin types V and VI in it; and if there is none, the chain of earlier devices it was compared with, back to the first one that had such data.
Why it is still open
The words are common and often carry no patient data. A diode laser cleared on 15 April 2026 (K260307) is indicated "for use on all skin types (Fitzpatrick Skin Types I-VI), including tanned skin", and its summary says no clinical study is included. Reviews have counted people with darker skin in laser trials as a group (Lebhar and colleagues, 2023, citing Akintilo and colleagues, 2022), but none traced the claim device by device. The free 510(k) browser at fda.innolitics.com already reads the summaries and notes their clinical evidence, so the reading is not new; the tracing and the counts are.
Built with what exists
The openFDA 510(k) interface for the list of clearances; the FDA's summary PDFs read with pdftotext; fda.innolitics.com pages; a small, cheap language model for pulling out predicates and participant counts, such as Meta's Muse Ember, which is built for extraction and long documents (Notes: "The jobs agents repeat"), with every count checked by hand.
First step
List the hair-removal clearances from 2025 and 2026 whose indication says I to VI, and read the first 20 summaries by hand.
Done looks like
Every such clearance in FDA product code GEX from 2016 to 2026, each with its predicate chain and the number of type V and VI participants behind its claim (zero where there are none), and 50 entries checked by a second person with full agreement on the counts.